Yale Cancer Center

This afternoon at #SSO2026, Dr. Jay Bader presents key findings on molecular profiling and #mesothelioma survival during the Trainee Abstract session in Room 106A-C.
@socsurgonc.bsky.social

Dr. Alexandra Gustafson will present research findings on TIL therapy for metastatic epithelial cancers during the #SSO2026 poster session starting at 2:12pm MST.
@socsurgonc.bsky.social

Representing @yalecancer.bsky.social at #PMWC2026, @williamohmd.bsky.social with Drs. Roy Herbst and Meina Wang are helping to shape the future of #PrecisionMedicine and #cancer care.

This afternoon at 3:10pm PST #hapc26, Dr. Prasanna Ananth
#YalePediatrics presents during a podium presentation on #endoflife preparation in #pediatriconcology.
@aahpm.bsky.social

We shared a wonderful evening at #SSO2026 hosted by
Dr. Kiran Turaga with colleagues, alumni & friends from #YaleSurgery and across the country. Grateful for the collaboration, mentorship & shared commitment to progress in cancer care.
@socsurgonc.bsky.social

New research presented by Dr. Nicole Aguirre at #SSO26 supports routine germline testing in appendiceal peritoneal surface malignancies.
▪️ > 1/3 harbored germline variants
▪️ 50% of alterations involved DNA repair pathways

@oncoalert.bsky.social @socsurgonc.bsky.social

Dr. Princy Gupta shows how mass-based response testing #MRT can guide treatment decisions in peritoneal metastases by identifying patients likely to resist therapy. Tumors flagged as resistant by MRT were strongly linked to progression. #SSO2026
@socsurgonc.bsky.social @oncoalert.bsky.social

Dr. Nicole Aguirre presents research findings on characterizing germline variants in peritoneal surface malignancies (PSM) of appendiceal origin during a #SSO2026 poster session today at 3pm MST.
@socsurgonc.bsky.social

This afternoon at 2:11pm MST, Dr. Princy Gupta will present findings that demonstrate #MRT as a functional precision-medicine tool to guide therapy selection in peritoneal metastases. Stop by Room 301A for her #SSO2026 poster session! @socsurgonc.bsky.social

Dr. Kiran Turaga reflects on the dedication and team behind the new consensus guidelines for peritoneal mesothelioma: “Now we have a way—we’re connected, advancing care, + doing what’s right for our patients. This consensus platform will help move the field forward.” #SSO2026
@socsurgonc.bsky.social

Dr. Leanne Brown presents an analysis of MSK-MET tumors #SSO2026 finding chromosome 12p gain may be a key biomarker in pancreatic ductal adenocarcinoma #PDAC, potentially identifying patients most likely to benefit from KRAS-targeted therapies.
@oncoalert.bsky.social

During our #GrandRounds, Dr. Daniel Petrylak was hailed as the ‘Father of Chemotherapy’ for #prostatecancer and shared his excitement for the future: "RIPTACs and bispecifics are incredibly promising, especially when combined with advancements in molecular sequencing." #pcsm
➡️ bit.ly/4rSHOsM

Dr. Leanne Brown to present a biomarker for aggressive pancreatic ductal adenocarcinoma in a #SSO2026 Quick Shot Poster Presentation today at 10:11am MST.
@socsurgonc.bsky.social

This morning at 9:34am MST, Dr. Kiran Turaga shares updates on the new consensus guidelines for peritoneal mesothelioma at #SSO2026.
@socsurgonc.bsky.social

🚨Attention Surgical Residents🚨
➡️Stop by our table today at the #SSO2026 Resident Meet & Greet from 12-1pm and meet the Program Directors for our Interdisciplinary Breast Surgery Fellowship Program:
💥Rachel Greenup, MD, MPH, FACS
💥Elizabeth Berger, MD, MS, FACS
@socsurgonc.bsky.social

We're pleased to share six E-Posters featured at #SSO2026. Congratulations, Kelsey LaBella, PA; and Drs. Syed Haider; Mohamad Othman El Helou; Lauren Raymond;Jay Bader; and Justus Gabriel!
@socsurgonc.bsky.social

Members of our surgical oncology team are attending the
@socsurgonc.bsky.social Annual Meeting! We are looking forward to seeing our colleagues and participating in cutting-edge educational sessions and presentations.
➡️Check out Yale’s presentations at #SSO2026: bit.ly/47jdOOr

Members of our Hospice and Palliative Care team will be at the
@aahpm.bsky.social Annual Assembly of Hospice and Palliative Care this week! We look forward to seeing our colleagues and sharing research and learning of new opportunities to advance patient care. #hap26

Our next #CME webinar #SmilowShares: Nomograms and Gene Expression Profiles for Cutaneous Malignancies features 6 of our experts sharing knowledge and insights into #nomograms and gene expression profile tests.
🗓️Thursday, April 9
⌚️6:30pm
➡️RSVP: bit.ly/4kWkYhj

Today at 12pm Dr. Daniel Petrylak presents our #GrandRounds on the topic of "Approaches to the Treatment of Metastatic Prostate Cancer." Join us in Smilow Auditorium or online via Zoom: bit.ly/4uojtNt

Congratulations to @adrianakahn.bsky.social, recipient of a @metavivor.bsky.social Early Career Investigator Award for “BERLIN: A Phase II Study of Sacituzumab Tirumotecan in Metastatic Triple-Negative Breast Cancer with Active Brain Metastases."
metavivor.org/grants/?_gra...

Don't miss part two of our Center for Gastrointestinal Cancers CME webinar series, Thursday, March 19 at 6:30pm.
➡️ Topic: Colorectal Liver Metastases
➡️ Moderator: Dr. Jeremy Kortmansky
➡️ Presenters: Drs. Sajid Khan, Kevin Du, David Madoff
➡️ RSVP: bit.ly/45N4Atd
@pamelakunzmd.bsky.social

Dr. Adriana Ramirez, endocrine surgeon, joins #YaleCancerAnswers tonight at 7:30pm to discuss #thyroidcancer.
💠 Listen live #WNPR
💠 Download on #ApplePodcasts
💠 Listen later #YouTube

This morning, Dr. Zachary Yochum presented research on cell-of-origin analysis for #renalcellcarcinoma. For this research, Dr. Yochum was awarded a #ConquerCancer Merit Award which recognizes outstanding research in abstracts at #ASCOGU26.
meetings.asco.org/meetings/2026-…
@braunmdphd.bsky.social

SurgOnc Today®: SSO Education Series: Reflecting on the Newly Updated PSM Consortium Guidelines Leaders in PSM and co-creators of the Yale consensus guidelines meet to discuss key aspects of the recently updated consortium recommendations.

Dr. Kiran Turaga joined the @socsurgonc.bsky.social podcast #SurgOncToday to discuss the newly endorsed guidelines from the Yale Peritoneal Surface Malignancy Consortium. #PSM
surgonctoday.libsyn.com/sso-educatio...

At 11:30am PST, Dr. Daniel Petrylak presents results of a QI initiative on 1st line combination therapy + biomarker testing in #urothelialcarcinoma in community settings. #ASCOGU26
meetings.asco.org/meetings/202...

Using Machine Learning to Develop Personalized Vaccines for Cancer A new tool combines multiple types of data to better support the development of vaccines that target patient-specific pathology.

Led by @virusesimmunity.bsky.social and @krishnaswamylab.bsky.social, a team of Yale researchers developed a new tool #Immunostruct that combines multiple types of data to better support the development of personalized vaccines, including vaccines for #cancer.
medicine.yale.edu/news-article...

In the Trials in Progress Poster Session A starting at 11:30am PST #ASCOGU26, Dr. Daniel Petrylak shares an update on the LuxAR-02 Phase II study for PSMA-positive metastatic castration resistant #prostatecancer. meetings.asco.org/meetings/202...

It's day one of #ASCOGU26, and starting at 11:30am PST,
@mleapman.bsky.social will present two posters during Poster Session A on #prostatecancer. meetings.asco.org/meetings/202...
@carygross.bsky.social

Congratulations to John Kunstman, MD, MHS, recipient of the
@yalecancer.bsky.social Clinical Excellence Award by Dr. Kiran Tiraga. Dr. Kunstman is a surgical oncologist specializing in the care of patients with cancers or benign diseases of the pancreas, liver, bile ducts, stomach, and intestines.